Unknown PHASE3 INTERVENTIONAL 4-arm NCT03635749

Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis (INSPIRES)

Intensive Statin and Antiplatelet Therapy for High-risk Intracranial or Extracranial Atherosclerosis (INSPIRES)

Sponsor: Beijing Tiantan Hospital

Conditions Acute Stroke Transient Ischemic Attack

Interventions Delayed high-intensity statin Immediate high-intensity statin Intensive antiplatelet Standard antiplatelet

Updated 12 times since 2018 Last updated: Jul 15, 2023 Started: Sep 17, 2018 Primary completion: Jan 15, 2023 Completion: Oct 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Acute Stroke and Transient Ischemic Attack, this trial is ongoing. The trial is conducted by Beijing Tiantan Hospital and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Aug 2025 — Sep 2025 [monthly]

Unknown PHASE3

Status: Active Not Recruiting → Unknown
Jun 2025 — Aug 2025 [monthly]

Active Not Recruiting PHASE3
Sep 2024 — Jun 2025 [monthly]

Active Not Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE3

▶ Show 7 earlier versions

Aug 2023 — Jul 2024 [monthly]

Active Not Recruiting PHASE3
May 2023 — Aug 2023 [monthly]

Active Not Recruiting PHASE3
Nov 2022 — May 2023 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Mar 2022 — Nov 2022 [monthly]

Recruiting PHASE3
May 2021 — Mar 2022 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jan 2021 — May 2021 [monthly]

Not Yet Recruiting PHASE3
Sep 2018 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Tiantan Hospital
Ministry of Science and Technology of the People´s Republic of China

Data source: Beijing Tiantan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anshan, China , Anyang, China , Baoding, China , Beijing, China , Benxi, China , Changsha, China , Changzhi, China , Changzhou, China , Chongqing, China , Dali, China and 73 more locations